−0.2ILS
−223.55 MILS
17.70 MILS
1.08 B
About BIOLINE RX
Sector
CEO
Philip Adam Serlin
Headquarters
Modi'in
Website
Employees (FY)
38
Founded
2003
ISIN
IL0011015182
FIGI
BBG000D3FWW6
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BLRX is 17.40 ILA — it has decreased by 3.33% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TASE exchange BIOLINE RX stocks are traded under the ticker BLRX.
BIOLINE RX is going to release the next earnings report on May 22, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for BIOLINE RX has a max estimate of 5.17 ILA and a min estimate of 1.60 ILA.
BLRX earnings for the last quarter are −0.08 ILA whereas the estimation was −0.05 ILA which accounts for −42.15% surprise. Estimated earnings for the next quarter are −0.05 ILA. See more details about BIOLINE RX earnings.
BIOLINE RX revenue for the last quarter amounts to 0 ILA despite the estimated figure of 0 ILA. In the next quarter revenue is expected to reach 544.64 K ILA.
Yes, you can track BIOLINE RX financials in yearly and quarterly reports right on TradingView.
Like other stocks, BLRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOLINE RX stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 38.00 employees. See our rating of the largest employees — is BIOLINE RX on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOLINE RX EBITDA is −153.94 M ILS, and current EBITDA margin is −866.81%. See more stats in BIOLINE RX financial statements.